Vir Biotechnology VIR
NASDAQ VIR
$11.17 -0.12 (-1.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Return on Assets [ROA] (2019 - 2026)

Updated

Vir Biotechnology (VIR) reported Return on Assets [ROA] of -22.47% for Q2 2026, up 21.55 percentage points from -44.01% a year earlier and up 21.18 percentage points from the prior quarter.

Analysis

Vir Biotechnology (VIR) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Vir Biotechnology posted Return on Assets [ROA] of -36.47%, down 5.01 percentage points from FY2024.

  • Return on Assets [ROA] has declined for four consecutive years, though with a five-year change of +5.27 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -31.46% in FY2024 (-5.41 pp), -26.06% in FY2023 (-47.75 pp), 21.69% in FY2022 (-15.11 pp) and 36.80% in FY2021 (+78.54 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q2 2023.
  • Year over year, Return on Assets [ROA] gained in 1 of the last eight quarters, with an average year-over-year change of -4.83 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2022 (a gain of 88.24 percentage points); the low point was Q3 2023 (a drop of 71.01 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -43.65% (Q1 2026), -43.32% (Q4 2025) and -45.18% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn -22.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.47%
Mar 31, 2026 -43.65%
Dec 31, 2025 -43.32%
Sep 30, 2025 -45.18%
Jun 30, 2025 -44.01%
Mar 31, 2025 -42.69%
Dec 31, 2024 -36.03%
Sep 30, 2024 -33.67%
Jun 30, 2024 -27.89%
Mar 31, 2024 -29.06%
Dec 31, 2023 -31.04%
Sep 30, 2023 -28.01%
Jun 30, 2023 -10.67%
Mar 31, 2023 -5.26%
Dec 31, 2022 18.76%
Sep 30, 2022 43.00%
Jun 30, 2022 39.15%
Mar 31, 2022 50.24%
Dec 31, 2021 33.41%
Sep 30, 2021 -9.02%
API Access

Vir Biotechnology Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VIR&period=max&api_key=YOUR_API_KEY